The groundbreaking success of Viagra, developed by copyright, undeniably reshaped the management of erectile dysfunctionality, and fueled a massive surge in the healthcare sector. However, currently , investing in firms reliant on aging blockbuster drugs like Viagra presents a complex landscape.